Abstract

From ancient times the people used different poisons as a treatment for diseases of different genesis. To date, almost nothing has changed. One of the main conditions for the development of a new drug is its low toxicity. Literature analysis has shown that 1,2,4-triazole-3-thione derivatives are low-toxic compounds and exhibit a wide range of pharmacological activities.
 The aim of this work was the investigate acute toxicity LC50 in vivo of sodium 2-((4-amino-5-(thiophen-2-ylmethyl)-4H-1,2,4-triazole-3-yl)thio)acetate on the Zebrafish (Danio rerio) aquatic model according to OECD instruction № 203.
 Materials and methods. Determination of acute toxicity LC50 of the test compound was performed in vivo on a model of the aquatic organism Zebrafish (Danio rerio) according to the instruction OECD № 203 (Fish, Acute Toxicity Test) for testing chemical compounds (acute toxicity test on fish from 10.12.2009).
 It was used fish 2 months of age, 11.8 ± 0.1 mm long, and weighing 2.6 ± 0.2 g in the experiment. The concentration of the test compound ranged from 5.0 mg/l to 100.0 mg/l. Test water-soluble compounds were dissolved in distilled water. Each mini-aquarium with a certain dose of the compound contained at least 7 individuals of Danio rerio. During the experiments, the fish were kept on a diet for a test 96 hours and their mortality was checked every 24, 48, 72 and 96 hours. Statistical analysis of the results was performed using the program Statistica 6.
 Results. According to the obtained data, graphs of the dependence of the concentration on the fish mortality percentage were constructed. Then the corresponding values of LC50 sodium 2-((4-amino-5-(thiophen-2-ylmethyl)-4H-1,2,4-triazole-3-yl)thio)acetate were calculated.
 According to the acute toxicity of LC50 (96 hours) of sodium 2-((4-amino-5-(thiophen-2-ylmethyl)-4H-1,2,4-triazole-3-yl)thio)acetate, which according to the classification of D. R. Passino and co-authors allowed it to be classified as a moderately toxic compound.
 Conclusions. The acute toxicity LC50 in vivo of sodium 2-((4-amino-5-(thiophen-2-ylmethyl)-4H-1,2,4-triazole-3-yl)thio)acetate on the Zebrafish (Danio rerio) aquatic model was investigated. The research was conducted in accordance with the national “General Ethical Principles of Animal Experimentation” approved by the First National Congress on Bioethics and the “Bioethical Expertise of Preclinical and Other Animal Research”.
 The highest fish mortality occurs on the last day of observation (96 hours). The highest number of Zebrafish deaths is at a minimum concentration of the substance. The acute toxicity LC50 (96 hours) of the test substance was 4.5364 mg/l.

Highlights

  • From ancient times the people used different poisons as a treatment for diseases of different genesis

  • Determination of acute toxicity LC50 of the test compound was performed in vivo on a model of the aquatic organism Zebrafish (Danio rerio) according to the instruction OECD No 203 (Fish, Acute Toxicity Test) for testing chemical compounds

  • The research was conducted in accordance with the national “General Ethical Principles of Animal Experimentation” approved by the First National Congress on Bioethics and the “Bioethical Expertise of Preclinical and Other Animal Research”

Read more

Summary

Introduction

From ancient times the people used different poisons as a treatment for diseases of different genesis. One of the main conditions for the development of a new drug is its low toxicity. Literature analysis has shown that 1,2,4-triazole-3-thione derivatives are low-toxic compounds and exhibit a wide range of pharmacological activities. The aim of this work was the investigate acute toxicity LC50 in vivo of sodium 2-((4-amino-5-(thiophen-2-ylmethyl)-4H-1,2,4-triazole-3-yl) thio)acetate on the Zebrafish (Danio rerio) aquatic model according to OECD instruction No 203

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.